- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03566342
Optimal Regimen of Patient-controlled Epidural Analgesia in Laboring Patients (PCEA)
June 20, 2018 updated by: kalpana tyagaraj, Maimonides Medical Center
Optimal Regimen of Patient-controlled Epidural Analgesia in Laboring Patients Receiving Combined Spinal and Epidural Analgesia (CSE)
To test the efficacy of different recipes of epidural infusions used for providing pain relief during labor in parturients.
Study Overview
Status
Terminated
Conditions
Detailed Description
In this prospective trial, the investigators would like to examine the efficacy of several different PCEA protocols in 250 parturients who receive CSE for labor pain.
Any patient with failed epidural, delivery within 2 hours of epidural insertion, or Cesarean section will be excluded from the study.
Each patient will be assigned to one of five groups (A - E), depending on the day of admission for delivery, excluding Friday and Saturday (observed religious holidays).
Each group will have 50 patients.
Study Type
Observational
Enrollment (Actual)
145
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 45 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Laboring women receiving combined spinal epidural analgesia for pain relief
Description
Inclusion Criteria:
Parturients receiving Combined Spinal epidural analgesia for labor pain relief.
Exclusion Criteria:
Any patient with failed epidural, delivery within 2 hours of epidural insertion, or Cesarean section will be excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
GROUP A
The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl.
Basal infusion 7 ml/hour Demand dose 8ml Lockout ( number of doses per hour) 2 Lock out interval 30 minutes
|
|
GROUP B
The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl.
Basal infusion 7 ml/hour Demand dose 5ml Lockout ( number of doses per hour) 4 Lock out interval 15 minutes
|
|
GROUP C
The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl.
Basal infusion 7 ml/hour Demand dose 3ml Lockout ( number of doses per hour) 6 Lock out interval 10 minutes
|
|
GROUP D
The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl.
Basal infusion 14 ml/hour Demand dose 0 ml Lockout ( number of doses per hour) 0 Lock out interval 0 minutes
|
|
GROUP E
The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl.
Basal infusion 7 ml/hour Demand dose 7ml Lockout ( number of doses per hour) 3 Lock out interval 20 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain scores
Time Frame: 24 to 48 hours.
|
From each patient investigators will collect pain scores to assess the severity of labor pain, using the Visual Analog Scale (VAS) scale, 1-10.
VAS score of 1 is considered minimal pain and VAS score of 10 is considered as the maximum pain.
|
24 to 48 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of boluses
Time Frame: 24 to 48 hours
|
From each patient the investigators will obtain information on total number of boluses of the epidural medication used
|
24 to 48 hours
|
|
Amount of medication used
Time Frame: 24 to 48 hours
|
From each patient the investigators will obtain information regarding the total amount of medications used in mls from reviewing the history on the PCEA pump.
|
24 to 48 hours
|
|
Motor block
Time Frame: 24 to 48 hours.
|
For each patient, the investigators will obtain information regarding degree of motor block using the Modified Bromage scale. Modified Bromage score:
|
24 to 48 hours.
|
|
Height of the patient
Time Frame: At recruitment of the patient in to the study
|
From each patient the investigators will obtain information on height in inches.
|
At recruitment of the patient in to the study
|
|
Weight of the patient
Time Frame: At recruitment of the patient in to the study
|
From each patient the investigators will obtain information on weight in pounds
|
At recruitment of the patient in to the study
|
|
Overall patient satisfaction
Time Frame: 24 to 48 hours
|
From each patient investigators will collect satisfaction scores to assess degree of satisfaction, using the Visual Analog Scale (VAS) scale, 1-10.
VAS score of 1 is considered minimal satisfaction and VAS score of 10 is considered as the maximum satisfaction.
|
24 to 48 hours
|
|
Mode of delivery
Time Frame: 24 to 48 hours
|
From each patient the investigators will obtain information regarding mode of delivery- vaginal delivery or C-Section
|
24 to 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: KALPANA TYAGARAJ, MAIMONIDES MEDICAL CENTER, 4802, 10TH AVENUE, BROOKLYN, NY-11219
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
April 6, 2018
First Submitted That Met QC Criteria
June 20, 2018
First Posted (Actual)
June 25, 2018
Study Record Updates
Last Update Posted (Actual)
June 25, 2018
Last Update Submitted That Met QC Criteria
June 20, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB #08/08/VA07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on LABOR PAIN
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanCompletedLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Roi TreisterHillel Yaffe Medical CenterNot yet recruitingLabor Pain and to Reduce PainIsrael
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
-
Mashhad University of Medical SciencesTerminatedDecrease Labor Pain